Form 8-K - Current report:
SEC Accession No. 0001477932-19-006702
Filing Date
2019-11-19
Accepted
2019-11-19 14:53:08
Documents
6
Period of Report
2019-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K imle_8k.htm 8-K 36746
2 BYLAWS imle_ex31.htm EX-3.1 123631
3 EQUITY INCENTIVE PLAN imle_ex101.htm EX-10.1 154947
4 EMPLOYMENT AGREEMENT imle_ex102.htm EX-10.2 92630
5 EMPLOYMENT AGREEMENT imle_ex103.htm EX-10.3 93775
6 PRESS RELEASE imle_ex991.htm EX-99.1 9104
  Complete submission text file 0001477932-19-006702.txt   512469
Mailing Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705
Business Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705 714-667-7139
TransBiotec, Inc. (Filer) CIK: 0001425627 (see all company filings)

EIN.: 260731818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53316 | Film No.: 191230791
SIC: 2721 Periodicals: Publishing or Publishing & Printing